http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106946973-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_91ba5b549cbd7a36dcf03d0bfbad3dc1 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J71-0005 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J71-00 |
| filingDate | 2017-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_987afc37170b95f7ae81105994713699 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_187326f3351d886ebe2d95635ddd6307 |
| publicationDate | 2017-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-106946973-A |
| titleOfInvention | A compound and its preparation method and use |
| abstract | The present invention belongs to the field of medicinal chemistry, and specifically relates to a compound and its preparation method and application, namely (3β,22α,25R)-spironalkane-5-enyl-3-O-β-D-glucopyranosyl ‑(1→2)‑O‑[β‑D‑xylopyranosyl‑(1→3)]‑O‑β‑D‑glucopyranosyl‑(1→4)‑β‑D‑pyranosyl‑(1→4)‑β‑D‑pyranosyl The new use of galactoside and its preparation method, the compound can inhibit lung cancer cells, stop the growth cycle of lung cancer cells in the early stage, and promote the apoptosis of lung cancer cells, therefore, the compound can be used to prepare anticancer drugs, especially Preparation of anti-lung cancer drugs. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111171107-A |
| priorityDate | 2017-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 45.